Dr Reddys (Germany) Performance
RDDA Stock | EUR 14.30 0.10 0.70% |
Dr Reddys has a performance score of 2 on a scale of 0 to 100. The firm owns a Beta (Systematic Risk) of 0.35, which means possible diversification benefits within a given portfolio. As returns on the market increase, Dr Reddys' returns are expected to increase less than the market. However, during the bear market, the loss of holding Dr Reddys is expected to be smaller as well. Dr Reddys Laboratories at this time owns a risk of 1.55%. Please confirm Dr Reddys Laboratories semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to decide if Dr Reddys Laboratories will be following its current price history.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dr Reddys Laboratories are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable fundamental indicators, Dr Reddys is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow | 14.8 B | |
Total Cashflows From Investing Activities | -26.4 B |
RDDA |
Dr Reddys Relative Risk vs. Return Landscape
If you would invest 1,390 in Dr Reddys Laboratories on September 23, 2024 and sell it today you would earn a total of 40.00 from holding Dr Reddys Laboratories or generate 2.88% return on investment over 90 days. Dr Reddys Laboratories is generating 0.0549% of daily returns assuming 1.5527% volatility of returns over the 90 days investment horizon. Simply put, 13% of all stocks have less volatile historical return distribution than Dr Reddys, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Dr Reddys Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dr Reddys' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Dr Reddys Laboratories, and traders can use it to determine the average amount a Dr Reddys' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0353
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | RDDA | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.55 actual daily | 13 87% of assets are more volatile |
Expected Return
0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Dr Reddys is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dr Reddys by adding it to a well-diversified portfolio.
Dr Reddys Fundamentals Growth
RDDA Stock prices reflect investors' perceptions of the future prospects and financial health of Dr Reddys, and Dr Reddys fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on RDDA Stock performance.
Return On Equity | 0.18 | |||
Return On Asset | 0.0949 | |||
Profit Margin | 0.15 % | |||
Operating Margin | 0.19 % | |||
Current Valuation | 8.47 B | |||
Shares Outstanding | 166.1 M | |||
Price To Earning | 23.95 X | |||
Price To Book | 3.61 X | |||
Price To Sales | 0.04 X | |||
Revenue | 214.39 B | |||
EBITDA | 48.86 B | |||
Cash And Equivalents | 306.55 M | |||
Cash Per Share | 1.85 X | |||
Total Debt | 5.75 B | |||
Debt To Equity | 23.50 % | |||
Book Value Per Share | 1,326 X | |||
Cash Flow From Operations | 28.11 B | |||
Earnings Per Share | 2.47 X | |||
Total Asset | 296.65 B | |||
About Dr Reddys Performance
By analyzing Dr Reddys' fundamental ratios, stakeholders can gain valuable insights into Dr Reddys' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Dr Reddys has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Dr Reddys has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. DR REDDYS operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 21966 people.Things to note about Dr Reddys Laboratories performance evaluation
Checking the ongoing alerts about Dr Reddys for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Dr Reddys Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Dr Reddys' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Dr Reddys' stock performance include:- Analyzing Dr Reddys' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Dr Reddys' stock is overvalued or undervalued compared to its peers.
- Examining Dr Reddys' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Dr Reddys' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Dr Reddys' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Dr Reddys' stock. These opinions can provide insight into Dr Reddys' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for RDDA Stock analysis
When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |